Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL


Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

01-Oct-2019 / 14:24 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


Sartorius Stedim Biotech S.A. - 13781 Aubagne Cedex, France

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DECLARATION RELATIVE TO

THE NUMBER OF SHARES AND VOTING RIGHTS

MAKING UP THE ISSUED CAPITAL

 

Article L 233-8-II of the Code of commerce

and article 223-6 of the general regulations of the AMF

 

 

 

 

 

Designation of issuer

 

 

 

SARTORIUS STEDIM BIOTECH SA

CS 91051

Z. I. Les Paluds

Avenue de Jouques

13781 Aubagne Cedex

 

 

 

 

Date of information
 

Total number of shares making up the issued capital

Total number of theoretical voting rights including treasury shares

Total number of net voting rights

September 30, 2019

92,180,190

160,980,410

160,978,030

 

 

 

 

 

 

 

 

 

 

 

 


Regulatory filing PDF file

Document title: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Document: http://n.eqs.com/c/fncls.ssp?u=RBMNGFIBHW


Language: English
Company: Sartorius Stedim Biotech SA
Avenue de Jouques
13781 Aubagne
France
Phone: +33 44 284 5600
E-mail: [email protected]
Internet: www.sartorius-stedim.com
ISIN: FR0013154002
Euronext Ticker: DIM
AMF Category: Total number of voting rights and share capital / Information on the total number of voting rights and the number of shares making up the share capital
EQS News ID: 883555
 
End of Announcement EQS News Service

883555  01-Oct-2019 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=883555&application_name=news&site_id=sharewise

Sartorius Stedim Biotech S.A. Aktie

188,70 €
-1,02 %
Ein signifikanter Verlust für Sartorius Stedim Biotech S.A. heute, um -1,02 %.

Like: 0
Teilen
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Rechtlicher Hinweis

Kommentare